303 related articles for article (PubMed ID: 34744751)
1. Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention.
Lucafò M; Curci D; Franzin M; Decorti G; Stocco G
Front Pharmacol; 2021; 12():772101. PubMed ID: 34744751
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.
Wang ZH; Fang JY
Gastrointest Tumors; 2014 Aug; 1(3):146-54. PubMed ID: 26674110
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and carcinogenesis.
Nagao-Kitamoto H; Kitamoto S; Kamada N
Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
6. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links.
Jurjus A; Eid A; Al Kattar S; Zeenny MN; Gerges-Geagea A; Haydar H; Hilal A; Oueidat D; Matar M; Tawilah J; Hussein IH; Schembri-Wismayer P; Cappello F; Tomasello G; Leone A; Jurjus RA
BBA Clin; 2016 Jun; 5():16-24. PubMed ID: 27051585
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy.
Nardone OM; Zammarchi I; Santacroce G; Ghosh S; Iacucci M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190315
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.
Majumder S; Shivaji UN; Kasturi R; Sigamani A; Ghosh S; Iacucci M
World J Gastrointest Oncol; 2022 Mar; 14(3):547-567. PubMed ID: 35321275
[TBL] [Abstract][Full Text] [Related]
12. New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer.
Lu L; Dong J; Liu Y; Qian Y; Zhang G; Zhou W; Zhao A; Ji G; Xu H
Front Pharmacol; 2022; 13():964793. PubMed ID: 36046819
[TBL] [Abstract][Full Text] [Related]
13. [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].
Hirsch D
Pathologe; 2019 Dec; 40(Suppl 3):232-238. PubMed ID: 31811372
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation.
Svrcek M; Borralho Nunes P; Villanacci V; Beaugerie L; Rogler G; De Hertogh G; Tripathi M; Feakins R;
J Crohns Colitis; 2018 Nov; 12(12):1486-1498. PubMed ID: 30202940
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?
Andersen V; Halfvarson J; Vogel U
World J Gastroenterol; 2012 Aug; 18(31):4091-4. PubMed ID: 22919240
[TBL] [Abstract][Full Text] [Related]
17.
Fredericks E; Dealtry G; Roux S
Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
[TBL] [Abstract][Full Text] [Related]
18. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).
Wang Z; Chang Y; Sun H; Li Y; Tang T
Oncol Lett; 2024 Jun; 27(6):257. PubMed ID: 38646499
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections.
Mignini I; Ainora ME; Di Francesco S; Galasso L; Gasbarrini A; Zocco MA
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370812
[TBL] [Abstract][Full Text] [Related]
20. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
